Overview

A Study Of Sunitinib In Combination With Capecitabine Compared With Capecitabine In Patients With Breast Cancer

Status:
Completed
Trial end date:
2011-06-01
Target enrollment:
Participant gender:
Summary
The treatment received with sunitinib plus capecitabine could delay tumor growth longer than with treatment with capecitabine alone.
Phase:
Phase 3
Details
Lead Sponsor:
Pfizer
Treatments:
Capecitabine
Sunitinib